Psygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility Jan 18, 2022
Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health… Jan 18, 2022
Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted… Jan 13, 2022
How Significant Are Recent Changes To Psychedelics Access In Canada? ‘It Can’t Be Understated’ Says Numinus CEO Jan 12, 2022
Health Canada’s Special Access Program Will Now Allow Doctors To Request Patient Access To Psychedelics Jan 5, 2022
What Health Canada’s New Special Access Program Amendments Mean For Medical Access To Psychedelics Dec 23, 2021
